Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines – Lessons for design of combination targeted therapy

Brian Park, Zakary L. Whichard, Seth J. Corey

Cancer Letters · 2012 · 43 citations · 39 references

DOIFull text

Open access

Concepts

References

39